{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:07:05Z","timestamp":1762160825172},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.expneurol.2010.04.016","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T04:31:31Z","timestamp":1273293091000},"page":"395-402","source":"Crossref","is-referenced-by-count":15,"title":["Dyskinetic potential of dopamine agonists is associated with different striatonigral\/striatopallidal zif-268 expression"],"prefix":"10.1016","volume":"224","author":[{"given":"Anna R.","family":"Carta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Frau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micaela","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.04.016_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1212\/WNL.49.2.393","article-title":"Ropinirole for the treatment of early Parkinson's disease","volume":"49","author":"Adler","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.04.016_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2010.04.016_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00008877-199903000-00006","article-title":"The predictive validity of the drug-naive bilaterally MPTP-treated monkey as a model of Parkinson's disease: effects of L-DOPA and the D1 agonist SKF 82958","volume":"10","author":"Andringa","year":"1999","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib4","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1523\/JNEUROSCI.5884-08.2009","article-title":"Pharmacological analysis demonstrates dramatic alteration of D1 dopamine receptor neuronal distribution in the rat analog of L-DOPA-induced dyskinesia","volume":"29","author":"Berthet","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"B\u00e9zard","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2010.04.016_bib6","first-page":"103","article-title":"DOPA-induced \u2018peak dose\u2019 dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys","volume":"45","author":"Blanchet","year":"1995","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.expneurol.2010.04.016_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mds.870110117","article-title":"Dyskinesia and wearing off following dopamine D1 agonist treatment in drug-na\u00efve 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates","volume":"11","author":"Blanchet","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2010.04.016_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/brain\/124.3.546","article-title":"Dopamine agonist induced dyskinesia are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey","volume":"124","author":"Boraud","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2010.04.016_bib9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1460-9568.2000.00089.x","article-title":"Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats","volume":"12","author":"Bordet","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0197-0186(99)00064-9","article-title":"Chronic D1 and D2 dopaminomimetic treatment of MPTP denervated monkeys: effects on basal ganglia GABA(A)\/benzodiazepine receptor complex and GABA content","volume":"35","author":"Calon","year":"1999","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2010.04.016_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/syn.10066","article-title":"Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-DOPA and A2A receptor blockade plus L-DOPA in dopamine-denervated rats","volume":"44","author":"Carta","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2010.04.016_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1460-9568.2005.03944.x","article-title":"Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment","volume":"21","author":"Carta","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00008877-200609000-00005","article-title":"How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease?","volume":"17","author":"Carta","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/syn.20527","article-title":"Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat","volume":"62","author":"Carta","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2010.04.016_bib15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0306-4522(98)00217-6","article-title":"Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions","volume":"88","author":"Chang","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.04.016_bib16","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","article-title":"Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation","volume":"66","author":"Darmopil","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.04.016_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2010.04.016_bib19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0014-2999(93)90476-X","article-title":"Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding","volume":"236","author":"Engber","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1073858403255839","article-title":"D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease","volume":"9","author":"Gerfen","year":"2003","journal-title":"Neuroscientist"},{"key":"10.1016\/j.expneurol.2010.04.016_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(96)00157-6","article-title":"Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys","volume":"719","author":"Goulet","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2010.04.016_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1353-8020(00)00062-6","article-title":"The use of pramipexole in Parkinson's disease: are its actions D(3) mediated?","volume":"7","author":"Guttman","year":"2001","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2010.04.016_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/exnr.1998.6819","article-title":"Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"151","author":"Henry","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019052-200312001-00002","article-title":"Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease","volume":"16","author":"Jenner","year":"2003","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of L-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl 3","key":"10.1016\/j.expneurol.2010.04.016_bib27","doi-asserted-by":"crossref","first-page":"S585","DOI":"10.1002\/mds.22022","article-title":"Preventing and controlling dyskinesia in Parkinson's disease\u2014a view of current knowledge and future opportunities","volume":"23","author":"Jenner","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2010.04.016_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.neuropharm.2009.01.019","article-title":"Evaluation of D2 and D3 dopamine receptor selective compounds on L-dopa-dependent abnormal involuntary movements in rats","volume":"56","author":"Kumar","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.04.016_bib29","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.57.9.1687","article-title":"Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial","volume":"57","author":"Lees","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.04.016_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0306-4522(96)00029-2","article-title":"Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors","volume":"73","author":"Le Moine","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.04.016_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/exnr.2002.8055","article-title":"Both short- and long-acting D-1\/D-2 dopamine agonists induce less dyskinesia than L-DOPA in the MPTP-lesioned common marmoset (Callithrix jacchus)","volume":"179","author":"Maratos","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.3672127","article-title":"A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor","volume":"238","author":"Milbrandt","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2010.04.016_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.ne.14.030191.002225","article-title":"Stimulus\u2013transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun","volume":"14","author":"Morgan","year":"1991","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuroscience.2003.08.010","article-title":"Normalization of glutamate decarboxylase gene expression in the entopeduncular nucleus of rats with a unilateral 6-hydroxydopamine lesion correlates with increased GABAergic input following intermittent but not continuous levodopa","volume":"123","author":"Nielsen","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.04.016_bib36","first-page":"S22","article-title":"Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model","volume":"47","author":"Obeso","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib37","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1523\/JNEUROSCI.15-05-03863.1995","article-title":"Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test","volume":"15","author":"Olsson","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib38","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q","article-title":"Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias","volume":"46","author":"Papa","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib39","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"key":"10.1016\/j.expneurol.2010.04.016_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.870130207","article-title":"De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset","volume":"13","author":"Pearce","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2010.04.016_bib41","series-title":"Stereotaxic Atlas of the Rat Brain","author":"Pellegrino","year":"1979"},{"key":"10.1016\/j.expneurol.2010.04.016_bib42","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/brain\/awh190","article-title":"Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism","volume":"127","author":"Picconi","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2010.04.016_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbr.2006.03.021","article-title":"Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment","volume":"171","author":"Pinna","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2010.04.016_bib44","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","article-title":"A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa","volume":"342","author":"Rascol","year":"2000","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.expneurol.2010.04.016_bib45","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.58.2.249","article-title":"Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease","volume":"58","author":"Rascol","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2003.09.001","article-title":"Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia","volume":"185","author":"Ravenscroft","year":"2004","journal-title":"Exp. Neurol."},{"issue":"Suppl. 4","key":"10.1016\/j.expneurol.2010.04.016_bib47","first-page":"17","article-title":"Long-term treatment with dopamine agonists in idiopathic Parkinson's disease","volume":"247","author":"Reichmann","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib48","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1742-4658.2008.06296.x","article-title":"Parkinson's disease: levodopa-induced dyskinesia and signal transduction","volume":"275","author":"Santini","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2010.04.016_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-4159.2008.05831.x","article-title":"L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice","volume":"108","author":"Santini","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.04.016_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0028-3908(00)00005-8","article-title":"CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury","volume":"39","author":"Schallert","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2010.04.016_bib51","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0896-6273(90)90106-P","article-title":"The regulation and function of c-fos and other immediate early genes in the nervous system","volume":"4","author":"Sheng","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2010.04.016_bib52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson's disease","volume":"11","author":"Simola","year":"2007","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.expneurol.2010.04.016_bib53","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.WNF.0000220818.71231.DF","article-title":"Switching from levodopa to the long-acting dopamine D2\/D3 agonist piribedil reduces the expression of dyskinesia while maintaining effective motor activity in MPTP treated primates","volume":"29","author":"Smith","year":"2006","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib54","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1523\/JNEUROSCI.13-12-05066.1993","article-title":"Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum","volume":"13","author":"Steiner","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib55","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/(SICI)1096-9861(19961223)376:4<530::AID-CNE3>3.0.CO;2-2","article-title":"Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction","volume":"376","author":"Steiner","year":"1996","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.expneurol.2010.04.016_bib56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2008.01.019","article-title":"Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets","volume":"211","author":"Stockwell","year":"2008","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.expneurol.2010.04.016_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006564.pub2","article-title":"Dopamine agonist therapy in early Parkinson's disease","author":"Stowe","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.expneurol.2010.04.016_bib58","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0306-4522(02)00535-3","article-title":"Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets","volume":"115","author":"Tel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.04.016_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn1346","article-title":"MAPK cascade signalling and synaptic plasticity","volume":"5","author":"Thomas","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2010.04.016_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0306-4522(95)00100-W","article-title":"A single injection of amphetamine or methamphetamine induced dynamic alterations in c-fos, zif\/268 and preprodynorphin messenger RNA expression in rat forebrain","volume":"68","author":"Wang","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.04.016_bib61","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol. Psychiatry"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:19:26Z","timestamp":1559081966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0014488610001536"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.04.016","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}